Virtual Clinical Trials Global Market Report 2023 – By Design (Observational Trials, Interventional Trials, Expanded Access Trials), By Phases (Phase I, Phase II, Phase III, Phase IV), By Indication (CNS, Autoimmuneor Inflammation, Cardiovascular Disease, Metabolicor Endocrinology, Infectious Disease, Oncology, Genitourinary, Ophthalmology, Other Indications) – Market Size, Trends, And Global Forecast 2023-2032

Virtual reality (VR) is an artificial environment created with software that is presented to the user so that the user stops believing and accepts it as a real environment. The main types of components in virtual reality in the healthcare market are hardware and software. The hardware virtual reality in healthcare includes headsets, goggles, and other accessories used in healthcare facilities for medical training, performing virtual surgeries, and other tasks to make the user feel immersed in the 3D environment. The main technologies used in VR in healthcare are full-immersive virtual reality, non-immersive virtual reality, and semi-immersive virtual reality, and it has various device types such as head-mounted displays, gerture-tracking devices, projectors and display units, among others. VR in healthcare is used in research and diagnostics, laboratories, hospitals and clinics, pharmaceutical companies, and others and is applied in patient care management, education and training, fitness management, pharmacy, surgery, and others. The global virtual reality in healthcare market is segmented - 1) By Component: Hardware, Software 2) By Technology: Full Immersive Virtual Reality, Non-Immersive Virtual Reality, Semi-Immersive Virtual Reality 3) By Device Type: Head-Mounted Display, Gesture-Tracking Device, Projectors and Display Units, Other Devices 4) By Application: Patient Care Management, Education And Training, Fitness Management, Pharmacy, Surgery, Other Applications 5) By End User: Research And Diagnostics, Laboratories, Hospitals And Clinics, Pharmaceutical Companies, Other End Users The global virtual reality in healthcare market size will grow from $2.07 billion in 2022 to $3.00 billion in 2023 at a compound annual growth rate (CAGR) of 45.1%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The market size of the virtual reality in healthcare is expected to grow to $13.76 billion in 2027 at a CAGR of 46.3%. The rise in incidences of neurological disorders is driving the growth of virtual reality in the healthcare market. Neurological disorders are diseases such as Alzheimer’s disease, Parkinson’s disease, dementia, multiple sclerosis, migraines, and others that affect the body’s central nervous system. Immersive VR technology assists in the development of promising applications for the treatment of neurological illnesses. Virtual Reality in Neurology is cost-efficient, patient-friendly, useful for both normal and pathological ageing, and gives ecological validity that standard neuropsychological tests do not provide. For instance, in February 2022, according to the World Health Organization (WHO), a Switzerland-based agency of the United Nations responsible for international public health, epilepsy affects about 50 million individuals worldwide, making it one of the most prevalent neurological conditions worldwide and people with epilepsy make up over 80% of the population in low- and middle-income nations. Therefore, the rise in incidences of neurological disorders is expected to fuel the growth of virtual reality in the healthcare industry going forward. Major players in the virtual reality in healthcare market are Samsung, Atheer Inc., Augmedix Inc., Firsthand Technology Inc., Microsoft Corporation, Medical Realities Ltd., Mindmaze, Medtronic Inc., Siemens Healthineers, Hologic Inc., Oculus VR, GE Healthcare and Orca Health Inc. Growing technological advancements are shaping virtual reality in the healthcare market. Major companies operating in virtual reality in the healthcare sector are focusing on developing new technological solutions for the healthcare industry to strengthen their position in the market. For instance, in March 2021, the National Health Service (NHS), a UK-based government department, launched a free treatment plan that uses virtual reality technology to help people with trypanophobia conquer their phobias and receive their vaccinations without anxiety. With this plan, patients can train their brains to overcome the fear of needles by engaging in learning exercises and breathing techniques. In January 2020, Teladoc Health, Inc., a US-based virtual healthcare company, acquired InTouch Health for an undisclosed amount. This acquisition enables Teladoc Health to become the first virtual care provider addressing the full range of acuity – from critical to chronic to everyday care – through a single solution across all locations of care globally. InTouch Health is a US-based company that provides virtual reality in healthcare. North America was the largest region in the virtual reality in healthcare market in 2022. The regions covered in the virtual reality in healthcare market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa. The countries covered in the Virtual Reality In Healthcare market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA. The virtual reality in the healthcare market includes revenues earned by entities by offering 3D environment to create more impactful visual experiences of space and human anatomy, lowering medical costs, decreasing traumatic events, and improving outcomes. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The virtual reality in healthcare market research report is one of a series of new reports from The Business Research Company that provides statistics on virtual reality in the healthcare market, including global market size, regional shares, competitors with a virtual reality in healthcare market share, detailed virtual reality in healthcare market segments, market trends and opportunities, and any further data you may need to thrive in the virtual reality in healthcare industry. This virtual reality in healthcare market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Virtual reality (VR) is an artificial environment created with software that is presented to the user in such a way that the user stops believing and accepting it as a real environment. The main types of virtual reality services are hardware and software. The various basis of services includes consulting, training, implementation, integration, operation, and maintenance that are used for healthcare, education, real estate, advertising, travel, gaming, entertainment, and other applications. Consulting is defined as the practise of providing expertise on a subject to a third party for a fee. Advisory or implementation services are also provided as part of the service. The global virtual reality services market is segmented - 1) By Type: Hardware, Software 2) By Basis of Service: Consulting, Training, Implementation, Integration, Operation, Maintenance 3) By Application: Healthcare, Education, Real Estate, Advertising, Travel, Gaming, Entertainment, Other Applications The global virtual reality services market size will grow from $9.32 billion in 2022 to $10.88 billion in 2023 at a compound annual growth rate (CAGR) of 16.8%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The market size of the global virtual reality services is expected to grow to $18.75 billion in 2027 at a CAGR of 14.6%. The virtual reality services in telehealth is a key factor driving the growth of the virtual reality services market. To support COVID-19 patients, thousands of doctors and nurses will require advanced skills, which will be supported by VR-powered tools to cope in a simulated world with an anticipated influx of COVID-19 patients. Training services by virtual reality designed particularly for coronavirus pathology scenarios are highly beneficial and realistic in today's situation and also enable medical students, doctors, and nurses to quickly apply studied principles and procedures to the real world. For instance, the XRHealth application allows the hospitals to treat incoming coronavirus victims who are in hospital quarantine and it allows the physicians to monitor them when they return home. Therefore, the increasing necessity of virtual reality services in telehealth is expected to drive the significant virtual reality services market growth. Major players in the virtual reality services market are Skywell Software, LittlStar, Creative Solutions, Gramercy Tech, HQSoftware, Program Ace, Groove Jones, Xicom Technologies, Zco Corporation, The Intellify, Quy Technology, Fluper, JPLoft Solution, Credencys Solutions, HorizonCore Infosoft, Quytech, Hedgehog Lab, IndiaNIC Infotech Limited, Chetu, Vakoms, Delta Reality, Dyfuzja, Cortex, Chocolate Milk & Donuts, NARSUN, and Setapp. The high cost associated with virtual reality services hampers the growth of the virtual reality services market. The best VR experience will cost a lot of money. The investment required for the VR experience is high. For instance, one needs to spend at least a few hundred dollars (on the low end) only for the graphics card itself, excluding other internals of the computer. The high-end virtual reality computer would cost $1,000 easily, and the high-end VR headset such as Vive or Oculus Rift from HTC would cost $599 and $799, respectively. Therefore, the high cost for a VR experience is expected to hinder the growth of the virtual reality services industry. Remote shopping with virtual reality is a key trend in the virtual reality services market. Many people are not doing offline shopping due to isolation and quarantine with the global COVID-19 outbreak and that does not mean e-commerce companies must also stop communicating with their customers and clients. Virtual reality alternatives opened great chances where businesses can offer potential customers new buying experiences without preventing their outreach. E-commerce companies could now reframe the experience for the customers and redesign their shopping journeys by using VR services. For instance, USA-based brand GAP developed a virtual Dressing Room app that allows the user to digitally try out clothes before making a purchasing decision. It will help customers to choose the right outfit and also contributes to the reduction of product returns and the reduction of expensive financial burdens for retailers. Asia-Pacific was the largest region in the virtual reality services market in 2022. North America was the second largest region in the global virtual reality services market share. The regions covered in the global virtual reality services market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa. The countries covered in the virtual reality services market are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK and USA. The virtual reality services market includes revenues earned by entities by providing virtual reality services that are used in different sectors such as aerospace, defense, gaming, entertainment, tourism, diagnostics and surgeries. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The virtual reality services market research report is one of a series of new reports from The Business Research Company that provides virtual reality services market statistics, including virtual reality services industry global market size, regional shares, competitors with a virtual reality services market share, detailed virtual reality services market segments, market trends and opportunities, and any further data you may need to thrive in the virtual reality services industry. This virtual reality services market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Artificial intelligence is a wide-ranging branch of computer science-related with building smart machines that can perform tasks that require human intelligence. The main technology types of artificial intelligence services are machine learning, computer vision, natural language processing (NLP), and others. Machine learning is an artificial intelligence (AI) program that allows systems to automatically learn and improve from experience without being explicitly programmed. The various software tools used include web-based and cloud application programming interface, processing and modeler, archiving, and data storage that are used to provide managed services and professional services. The services are used by different end users such as banking, financial, and insurance (BFSI), IT and telecom, retail, manufacturing, public sector, energy and utility, and healthcare, among others. The global artificial intelligence services market is segmented – 1) By Technology: Machine Learning, Computer Vision, Natural Language Processing (NLP), Other Technology 2) By Services Type: Managed Services, Professional Services 3) By Software Tools: Web-based and Cloud Application Programming Interface, Processing and Modeler, Archiving and Data Storage 4) By Application Type: Fraud Detection, Data Analytics & Visualization, Customer Service and Management, Rsik Management, Compliance & Security 5) By End-User: Banking, Financial, and Insurance (BFSI), IT & Telecom, Retail, Manufacturing, Public Sector, Energy & Utility, Healthcare, Other End-Users The global artificial intelligence services market size will grow from $12.39 billion in 2022 to $18.34 billion in 2023 at a compound annual growth rate (CAGR) of 48.0%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The market size of the global artificial intelligence services is expected to grow to $55.38 billion in 2027 at a CAGR of 31.8%. The rise in the adoption of cloud-based solutions is a key factor driving the growth of the artificial intelligence services market. Artificial intelligence (AI) as a service lets businesses experiment with AI for different activities without a high initial investment. Experimentation enables many cloud computing platforms to check different machine learning algorithms and helps streamline how data is analyzed and managed. Businesses are deeply interested in cloud-based machine learning, which lets them experiment through their services and help their clients make informed decisions based on the data. For instance, in March 2020, Google announced the beta launch of Cloud AI Platform Pipelines, which provides its customers with repeatable machine learning pipelines that can be installed easily and used for machine learning workflows securely. The integration of AI applications into its cloud draws more customers, thus enhancing market growth over the forecast period. Therefore, the rise in the adoption of cloud-based solutions is expected to drive the growth of the artificial intelligence services market. Major players in the artificial intelligence services market are Intel Corp., International Business Machines Corp., Microsoft Corp., SAP SE, SAS Institute Inc., Amazon.com Inc., Salesforce, Google LLC., Oracle Corporation, Fair Isaac Corporation, Alphabet Inc., Apple Inc., CognitiveScale, Inc., Baidu, Inc., BigML, H2O.ai and Baidu Inc. The risks associated with data breaches and hacks are hampering the growth of the artificial intelligence services market. The World Economic Forum (WEF) has cautioned that new technologies such as the Internet of Things, artificial intelligence, and quantum computing can turn around human lives, but may also make society more vulnerable to cyber-attacks. It was stated that attacks occur on average once every 39 seconds and a single breach could cost as much as $150 million in 2020. Although companies and organizations are aware of these risks, breach activity still takes around six months to detect, and the long delays between original network breach and security responses allow hackers to take advantage of significant quantities of data. According to the State of the breach June 2020, about 16 billion records including credit card numbers, phone numbers, home addresses, and other sensitive information were exposed through data breaches since 2019. Therefore, the risks associated with data breaches and hacking hampers the growth of the artificial intelligence services market. The use of artificial intelligence as a service for human interaction with machines using natural language processing (NLP) is a key trend shaping the artificial intelligence services market. Natural language processing (NLP) is a type of artificial intelligence that explains how human language and computers interact. Machine translation is an enormous technology for NLP that enables us to overcome the challenges to contact people from all over the world and to understand software manuals and catalogs written in a foreign language. For instance, the Livox app, a customizable application in 25 languages helps the disabled to communicate. In January 2021, ServiceNow, a US-based provider of information technology management software for companies, acquired Element AI for $230 million. The acquisition of Element AI would significantly strengthen ServiceNow's commitment to developing the most intelligent workflow platform in the world, allowing staff members to work more quickly and intelligently, simplify business choices, and reach new heights of productivity. Element Ai is a Canada-based artificial intelligence (AI) company. Asia-Pacific was the largest region in the artificial intelligence services market in 2022. North America was the second largest region in the global artificial intelligence services market share. The regions covered in the global artificial intelligence services market analysis report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa. The countries covered in the artificial intelligence services market are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK and USA. The artificial intelligence services market includes revenues earned by entities by providing AI services that are used in telecommunications, government, retail, defense and healthcare. Companies in the artificial intelligence market provide outsourced services to cater to business requirements. AI as a service enables individuals and businesses to use AI for different purposes, without significant initial investment and with lower risk. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The artificial intelligence (AI) services market research report is one of a series of new reports from The Business Research Company that provides artificial intelligence (AI) services market statistics, including artificial intelligence (AI) services industry global market size, regional shares, competitors with an artificial intelligence (AI) services market share, detailed artificial intelligence (AI) services market segments, market trends and opportunities, and any further data you may need to thrive in the artificial intelligence (AI) services industry. This artificial intelligence (AI) services market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Next generation sequencing (NGS) is a process used to determine the sequence of nucleotides in a section of DNA and is used in oncology research. NGS is used to identify rare cancer mutations and familial cancer mutation carriers and to provide molecular rationale for appropriate targeted therapy. The main technologies in clinical oncology next-generation sequencing are ion semiconductor sequencing, pyro-sequencing, synthesis sequencing, real-time sequencing, ligation sequencing, reversible dye termination sequencing, and nanopore sequencing. Ion semiconductor sequencing is a technique of DNA sequencing found on the observation of hydrogen ions that are released throughout the polymerization of DNA. The clinical oncology next-generation sequencing is used in various applications such as screening, companion diagnostics, and other diagnostics that are used by various end-users such as hospital laboratories, clinical research organizations, and diagnostic laboratories. The global clinical oncology next-generation sequencing market is segmented - 1) By Technology: Ion Semiconductor Sequencing, Pyro-Sequencing, Synthesis Sequencing, Real Time Sequencing, Ligation Sequencing, Reversible Dye Termination Sequencing, Nano-Pore Sequencing 2) By Application: Screening, Companion Diagnostics, Other Diagnostics 3) By End User: Hospital Laboratories, Clinical Research Organizations, Diagnostic laboratories The global clinical oncology next-generation sequencing market grew from $0.39 billion in 2022 to $0.45 billion in 2023 at a compound annual growth rate (CAGR) of 14.7%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The market size of clinical oncology next-generation sequencing is expected to grow from $0.75 billion in 2027 at a CAGR of 13.7%. The rise in the number of cancer cases across the globe is likely to contribute to the growth of the clinical oncology next-generation sequencing market during the forecast period. According to the American Cancer Society, there were 1.9 million new cases and 0.6 million cancer deaths in 2021 in the USA. The four most common types of cancer worldwide are lung, prostate, bowel, and female breast cancer, accounting for 43% of all the new cancer cases. Therefore, the rise in cancer incidence rate globally is anticipated to boost the demand for the growth of the clinical oncology next-generation sequencing market. Major players in the clinical oncology next-generation sequencing market are Thermo Fisher Scientific (Qiagen), Oxford Nanopore Technologies, QIAGEN, Myriad Genetics, Illumina, F. Hoffmann-La Roche, Perkin Elmer, Agilent Technologies, Pacific Bioscience, and Caris Life Sciences. High costs associated with the clinical oncology next-generation sequencing are a major issue faced by patients across the globe. The pressure to contain costs and demonstrate value is widespread. Political uncertainty and persistent economic stress in numerous countries are calling into question the sustainability of public health care funding. In low-income countries, the lack of cost-effective therapies for cancer has influenced the health conditions of the population and has led to a low average life expectancy. According to an article published in 2020 by Genetics in Medicine, the genome sequencing costs per cancer case is around £6,841, and costs per rare disease are around £7,050, and this cost is due to consumables that are the most expensive components in the sequencing process, and the equipment cost for rare cancer disease is higher when compared with normal cancer equipment, thus restraining the growth of the market. Companies in the clinical oncology next-generation sequencing are increasingly investing in automation of workflow to increase precision and reduce the sample-to-sample variability. For instance, Agilent automation solutions have developed an automation system that allows increasing the number of reactions that can perform in parallel, reducing the amount of sample processing time, and increasing the number of samples which can be processed while reducing the variability amount from sample to sample. Companies such as Sophia Genetics are also investing in data-driven medicine that looks into automating DNA sequencing to better diagnose and treat patients. In April 2021, Agilent Technologies, a US-based life sciences technology company, acquired Resolution Bioscience for an undisclosed amount. The acquisition would expand Agilent's capabilities in the fields of next-generation sequencing for cancer diagnostics. Resolution Bioscience is a US-based developer of next-generation sequencing (NGS)-based precision oncology solutions. North America was the largest region in the clinical oncology next-generation sequencing market in 2022. Asia-Pacific was the second largest region in the global clinical oncology next-generation sequencing market share. The regions covered in the global clinical oncology next-generation sequencing market analysis report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa. The countries covered in the clinical oncology next-generation sequencing market are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, the UK, and the USA. The clinical oncology next-generation sequencing market consists of sales of genetic sequencing equipment with advanced features and technologies such as ion semiconductors sequencing, pyro-sequencing, synthesis sequencing (SBS), real-time sequencing (SMRT), ligation sequencing, and other techniques that are used in oncology research for determining the nucleotide sequence leading to clinical oncology. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The clinical oncology next-generation sequencing market research report is one of a series of new reports from The Business Research Company that provides clinical oncology next-generation sequencing market statistics, including clinical oncology next-generation sequencing industry global market size, regional shares, competitors with a clinical oncology next-generation sequencing market share, detailed clinical oncology next-generation sequencing market segments, market trends and opportunities, and any further data you may need to thrive in the clinical oncology next-generation sequencing industry. This clinical oncology next-generation sequencing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Clinical decision support systems (CDSS) are computer-based programs that analyze data within electronic health records (EHRs) to provide health care providers with reminders to assist them at the point of care to implement evidence-based clinical guidelines. The clinical decision support systems (CDSS) market consists of sales of clinical decision support systems by entities (organizations, sole traders, partnerships) that are used by nurses to facilitate decision-making through patient status as connecting evidence. Clinical decision support systems (CDSS) are computer-based programs that analyze data within electronic health records (EHRs) to provide health care providers with reminders to assist them at the point of care to implement evidence-based clinical guidelines. The main components of clinical decision support systems are services, software, and hardware. The different models include knowledge-based CDSS and non-knowledge-based CDSS and involve various delivery modes such as premise and cloud-based. The on-premise CDSS is used in-house and within an enterprise's IT infrastructure. On-Premise clinical decision support systems software refers to the software that is installed and runs on computers in a premise or organization. It is used in medical diagnosis, alerts and reminders, prescription decision support, information retrieval, and other applications that are employed in clinics, hospitals, ambulatory surgical centers, and other end users. The global clinical decision support systems market is segmented - 1) By Component: Services, Software, Hardware 2) By Model: Knowledge-Based CDSS, Non-Knowledge CDSS 3) By Delivery Mode: On Premise, Cloud Based 4) By Application: Medical Diagnosis, Alerts And Reminders, Prescription Decision Support, Information Retrieval, Other Applications 5) By End-User: Clinics, Hospitals, Ambulatory Surgical Centers, Others End Users The global clinical decision support systems market size grew from $2.45 billion in 2022 to $2.75 billion in 2023 at a compound annual growth rate (CAGR) of 12.2%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The market size of the global clinical decision support systems is expected to grow to $4.22 billion in 2027 at a CAGR of 11.3%. An increase in the adoption of information systems by hospitals is expected to drive the clinical decision support systems market growth going forward. Information systems consist of the software and hardware systems that are used to collect, store, and process data. Information systems are being adopted by healthcare facilities to promote smooth functioning and seamless clinical data flow. For instance, in 2021, according to the International Data Corporation (IDC), a US-based advisory services company, healthcare IT spending in Asia is expected to reach USD 14.9 billion by 2022. Hence, an increase in the adoption of information systems by hospitals is promoting clinical decision support systems market growth. Major players in the clinical decision support systems market are Cerner Corporation, Epic Systems Corporation, Meditech Medical Limited, Wolters Kluwer Health Inc., Zynx Health Incorporated, Elsevier B.V., IBM Watson Health, NextGen Healthcare Inc., Siemens Healthineers AG, Allscripts Healthcare Solutions Inc., Change Healthcare, Medical Information Technology Inc., Koninklijke Philips NV, and Athena Health Care Private Limited. Technological advancements have emerged as the key trend gaining popularity in the clinical decision support systems market. Major companies operating in the clinical decision support systems market are focused on developing new technological solutions to strengthen their position in the market. For instance, in April 2022, Change Healthcare, a US-based healthcare technology company, launched a clinical decision support solution, InterQual, for evidence-based care. This includes interactive and restructured criteria to streamline workflow and artificial intelligence to drive proactive insights. This can predict if a patient is required to be placed under observation or whether the patient requires a short-term or long-term stay. In April 2021, Halma PLC., a UK-based technology company, acquired PeriGen Inc. for an amount of $58 million. With this acquisition, Halma PLC. aimed to broaden the company's presence in patient monitoring and assessment in the US perinatal care market and further extend its analytics and artificial intelligence capabilities. PeriGen, Inc. is a US-based company that provides perinatal decision support software. North America was the largest region in the clinical decision support systems market in 2022. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the clinical decision support systems market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. The countries covered in the clinical decision support systems market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA. The clinical decision support systems (CDSS) market consists of sales of knowledge based CDSS, and non knowledge-based CDSS. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The clinical decision support systems market research report is one of a series of new reports from The Business Research Company that provides clinical decision support systems market statistics, including clinical decision support systems industry global market size, regional shares, competitors with a clinical decision support systems market share, detailed clinical decision support systems market segments, market trends and opportunities, and any further data you may need to thrive in the clinical decision support systems industry. This clinical decision support systems market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

Clinical workflow solutions refer to solutions that help with improving information exchange, coordinating care, improving quality of care, and meeting regulatory requirements. The main types of clinical workflow solutions are real-time communication solutions; data integration solutions; workflow automation solutions; enterprise reporting and analytics solutions; and care collaboration solutions. Real-time communications (RTC) is any mode of telecommunication in which all users can exchange information instantly or with negligible latency or transmission delays. The applications involved are diagnostic, research, and therapeutic applications. The various end-users involved are ambulatory care centers, long-term care facilities, and hospitals. The global clinical workflow solutions market is segmented - 1) By Type: Real-Time Communication Solutions, Data Integration Solutions, Workflow Automation Solutions, Enterprise Reporting and Analytics Solutions, Care Collaboration Solutions 2) By Application: Diagnostic Applications, Research Applications, Therapeutic Applications 3) By End-User: Ambulatory Care Centers, Long-Term Care Facilities, Hospitals The global clinical workflow solutions market size grew from $8.01 billion in 2022 to $9.24 billion in 2023 at a compound annual growth rate (CAGR) of 15.4%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The market size of the global clinical workflow solutions is expected to grow to $15.82 billion in 2027 at a CAGR of 14.4%. The rising prevalence of diseases is expected to propel the growth of the clinical workflow solutions market going forward. Disease is defined as a condition that impairs the normal functioning of the human body and is manifested by distinct signs and symptoms. Clinical workflows help patients suffering from various diseases by improving the functionality of the healthcare system and offering better healthcare system experiences. For instance, in 2020, according to the World Health Organization, a Switzerland-based government agency, chronic disease prevalence is expected to rise by 57%. Further, in 2021, according to the International Diabetes Federation, a Belgium-based organization, approximately 537 million adults (20–79 years) were living with diabetes, and the total number of people living with diabetes has been projected to rise to 643 million by 2030 and 783 million by 2045. Therefore, the rising prevalence of diseases is driving the clinical workflow solutions industry. Major players in the clinical workflow solutions market are Allscripts Healthcare Solutions Inc., Ascom Holding AG, Cerner Corporation, Cisco Systems Inc., GE Healthcare, Hill-Rom Holdings Inc., Infor Inc., Koninklijke Philips NV, Mckesson Corporation, Stanley Black and Decker Inc., NXGN Management LLC, Spok Inc., AMETEK Inc., Vocera Communications Inc., and Capsule Technologies Inc. Rapid technological advancements are a key trend that is gaining popularity in the clinical workflow solutions market. Major companies operating in the market are engaging in technological advancements such as the use of conversational AI in clinical workflow automation along with machine learning to sustain their position in the market. For instance, in May 2022, Mindray, a Chinese medical instrument manufacturer, launched the M-connect IT solution in a hospital in Haryana, India. The new offering is helpful in optimizing clinical workflow and ensuring patient safety. It also features M-Connect IT platform, which helps to digitally connect ICU patients with their doctors. In February 2022, Bain Capital, a US-based private investment firm, and Hellman & Friedman, a US-based private equity firm, acquired Athenahealth for an amount of $17 billion. With this acquisition, they aim to drive the next phase of their growth journey. Athenahealth is a US-based company that provides clinical workflow solutions. North America was the largest region in the clinical workflow solutions market in 2022. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the clinical workflow solutions market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa. The countries covered in the clinical workflow solutions market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA. The clinical workflow solutions market consists of sales of zero footprint workflow and clinical information management solution. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The clinical workflow solutions market research report is one of a series of new reports from The Business Research Company that provides clinical workflow solutions market statistics, including clinical workflow solutions industry global market size, regional shares, competitors with a clinical workflow solutions market share, detailed clinical workflow solutions market segments, market trends and opportunities, and any further data you may need to thrive in the clinical workflow solutions industry. This clinical workflow solutions market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

Healthcare cloud computing refers to integration of could computing services in healthcare which use remote servers accessed through the internet to store, manage, and process healthcare-related data. Healthcare cloud computing allows professionals and individuals to maintain electronic medical records for storing information about patient interactions, reduce data storage costs, offer superior data security, and more. The main healthcare cloud computing deployment models include private cloud, hybrid cloud, and public cloud. A private cloud is a model of cloud computing where the infrastructure is dedicated to a single user organisation and offers more control over and better security for private cloud servers. These healthcare cloud computing services are used by end users such as healthcare providers and healthcare payers. The different pricing models include pay-as-you-go and spot pricing. The different healthcare cloud computing service models include software-as-a-service (SaaS), infrastructure-as-a-service (IaaS), and platform-as-a-service (PaaS), which are used for applications that include clinical information systems and non-clinical information systems. The global healthcare cloud computing market is segmented - 1) By Deployment Model: Private Cloud, Hybrid Cloud, Public Cloud 2) By End User: Healthcare Providers, Healthcare Payers 3) By Pricing Model: Pay-as-you-go, Spot Pricing 4) By Service Model: Software-as-a-Service (SaaS), Infrastructure-as-a-Service (IaaS), Platform-as-a-Service (PaaS) 5) By Application: Clinical Information System, Non-Clinical Information System The global healthcare cloud computing market size will grow from $32.5 billion in 2022 to $37.29 billion in 2023 at a compound annual growth rate (CAGR) of 14.7%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The market size of the healthcare cloud computing is expected to grow to $66.08 billion in 2027 at a CAGR of 15.4%. The rise in the adoption of information technology in the healthcare sector is significantly driving the growth of the healthcare cloud computing market. Information technology has paved the way for more precise healthcare services that help patients attain easy and quick access to various healthcare facilities. The most common examples of health information technology are electronic health records (EHRs), e-prescriptions, and other tech tools that help patients meet health goals such as managing blood sugar levels or quitting smoking. According to the 2021 Accenture health and life science experience survey of 1,800 people in the United States, nearly 26% said their access to healthcare has been even better with digital adoption since the onset of the COVID-19 pandemic. Thus, a rise in the adoption of information technology in the healthcare sector is expected to drive the healthcare cloud computing market growth. IBM, Carestream Health, athenahealth, Siemens Healthineers, GE Healthcare, Cisco Systems Inc., Iron Mountain Inc., Microsoft Corp., Oracle Corp., Care Cloud Corporation, ClearDATA, Dell, Agfa-Gevaert N.V., VMware Inc., and Allscripts Healthcare Solution Inc. are major players in the healthcare cloud computing industry. Technological advances in healthcare infrastructure are a key trend gaining popularity in the healthcare cloud computing market. Major companies operating in the healthcare cloud computing sector are focused on developing new technological solutions to strengthen their position. For instance, in September 2021, a US-based neuroscience software company, MetaCell, introduced MetaCell Cloud Hosting, offering advanced cloud computing solutions to facilitate research and innovation in life science and healthcare organizations of all sizes. In January 2020, MTBC, a US-based company operating in cloud-based software in healthcare, acquired CareCloud, Inc. for a deal of $40.5 million. Through this acquisition, MTBC aims to expand its offering in EHR, PM, RCM, patient experience, billing, and other healthcare analytics. CareCloud, Inc. is a US-based healthcare information technology company. Asia-Pacific was the largest region in the healthcare cloud computing market in 2022. North America is expected to be the fastest-growing region in the forecast period. The regions covered in the healthcare cloud computing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa. The countries covered in the healthcare cloud computing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, the UK, and the USA. The healthcare cloud computing market includes revenues earned by entities by providing on-demand hosted services, quick access to business applications, customer relationship management (CRM), on-demand computing, large storage for medical facilities, secured web-based services and deployment of cloud applications. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The healthcare cloud computing market research report is one of a series of new reports from The Business Research Company that provides healthcare cloud computing market statistics, including healthcare cloud computing industry global market size, regional shares, competitors with a healthcare cloud computing market share, detailed healthcare cloud computing market segments, market trends and opportunities, and any further data you may need to thrive in the healthcare cloud computing industry. This healthcare cloud computing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Preventive healthcare technologies include screenings, check-ups, and patient counselling to identify and prevent health problems. Preventive healthcare technology devices are more commonly used to measure daily lives health patterns like blood oxygen saturation, heart rate, blood pressure, and sleep patterns. The preventive healthcare technologies and services are used to take measures and identify future illnesses and treatment by the healthcare providers. The main types of preventive healthcare technologies and services market are early detection and screening technologies, vaccines, chronic disease management technologies, advanced technologies to reduce errors. Early detection and screening technologies are used to identify future health conditions of patients. The early detection and screening technologies include x-ray, CT, ultrasound, magnetic resonance imaging (MRI). The applications of preventive healthcare technologies and services are in hospitals and clinics. The global preventive healthcare technologies and services market is segmented - 1) By Type: Early Detection and Screening Technologies, Vaccines, Chronic Disease Management Technologies, Advanced Technologies to Reduce Errors 2) By Application: Hospitals, Clinics The global preventive healthcare technologies and services market size grew from $220.95 billion in 2022 to $251.83 billion in 2023 at a compound annual growth rate (CAGR) of 14.0%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The preventive healthcare technologies and services market size is expected to grow to $441.5 billion in 2027 at a CAGR of 15.1%. An increase in the older population pool is increasing demand for the preventive healthcare technologies and services market. Medical problems are known to increase with age, due to this preventing or identifying problems at an early stage can decrease the risk and intensity of the issue. According to the United Nations survey, an intergovernmental organization, there were around 727 million persons that were aged above 65 years or above in 2020 and it is projected to reach around 1.5 billion in 2050. This increase in the aged people population can also directly impact the preventive healthcare technologies market. Major players in the preventive healthcare technologies and services market is Omnicell Inc., Merck & Co. Inc., McKesson Corporation, GlaxoSmithKline plc., Medtronic, Quest Diagnostics Inc., Alere, Myriad Genetics Inc., Omron Healthcare, Pfizer Inc., Sanofi, Healthway, Inc., Tivity Health, Dilon Technologies Inc., Novx Systems, Scripto LLC, Viatronix Inc., U-Systems Inc. The use of artificial intelligence (AI) as a preventive healthcare technique is a rising trend in the preventive healthcare technologies and services market. Many medical conditions such as identifying type 1 diabetes, indications of Alzheimer's, and predicting breast cancer, cardiovascular diseases can be identified using the advanced AI technologies. Some orthopedic spine surgery experts from Boston-based Massachusetts General Hospital suggest that machine learning and AI can also predict personalized and accurate assumptions of where fractures will happen on a patient based on the history of the patient and the historic database available. Similarly, in November 2020, Medtronic, American-Irish registered medical device company acquired France based company, Medicrea that provides AI-driven surgical planning and predictive modelling tools which helps to improve the quality of spine management. In November 2021, Hellman & Friedman and Bain Capital, a private equity firm, acquired Athenahealth, Inc for $17 billion. This acquisition will help Athenahealth become the largest and most innovative provider of cloud-based electronic medical records and physician practice solutions in the USA. Athenahealth, Inc is a cloud computing vendor that enhances the clinical quality, operational efficiency, and delivery of preventive care to many patients in the US. North America was the largest region in the preventive healthcare technologies and services market in 2022. Europe is expected to be the fastest-growing region in the forecast period. The regions covered in the preventive healthcare technologies and services market analysis report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. The countries covered in the preventive healthcare technologies and services market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA. The preventive healthcare technologies market includes revenues earned by entities remote patient monitoring, 5G-enabled devices, and wearable sensors. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The preventive healthcare technologies and service market research report is one of a series of new reports from The Business Research Company that provides preventive healthcare technologies and service market statistics, including preventive healthcare technologies and service industry global market size, regional shares, competitors with a preventive healthcare technologies and service market share, detailed preventive healthcare technologies and service market segments, market trends and opportunities, and any further data you may need to thrive in thepreventive healthcare technologies and service industry. This preventive healthcare technologies and service market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.